Jake Gatof represents life sciences and technology companies, as well as their sponsors, through all stages of growth and investment. Jake joined the Boston office upon its founding, representing companies throughout their business life cycle, including with respect to venture capital financings, corporate governance, mergers and acquisitions, and other complex strategic transactions. He also represents leading growth equity, venture capital, and other institutional sponsors in connection with their investments, acquisitions, and other strategic transactions.
Jake Gatof represents life sciences and technology companies, as well as their sponsors, through all stages of growth and investment. Jake joined the Boston office upon its founding, representing companies throughout their business life cycle, including with respect to venture capital financings, corporate governance, mergers and acquisitions, and other complex strategic transactions. He also represents leading growth equity, venture capital, and other institutional sponsors in connection with their investments, acquisitions, and other strategic transactions.
- J.D., University of Michigan Law SchoolMagna Cum Laude, Order of the Coif
- B.A., University of MichiganWith High Honors
- State Bar of Massachusetts
- State Bar of Illinois
- J.D., University of Michigan Law SchoolMagna Cum Laude, Order of the Coif
- B.A., University of MichiganWith High Honors
- State Bar of Massachusetts
- State Bar of Illinois
Select Publications
- Author, “Evaluating Prospective Partners When Scaling Your Digital Health Company,” Digital Health Report,. Spring/Summer Q2 2018
- Co-author, "The Serious and Immense Impact of a Medical Device Hack," Law360, January 12, 2017
- Co-author with K. Ludlow, D.M. Bowman, and M.G. Bennett, "Regulating Emerging and Future Technologies in the Present," 9 NanoEthics 151, 2015
- Co-author with D.M. Bowman, "Reviewing the Regulatory Barriers for Nanomedicine: Global Questions and Challenges," 10(21) Nanomedicine 3275-86, 2015
Select Speaking Engagements
- Speaker, “Term Sheet Tear-Down," inSite at Harvard Business School/MIT Sloan, Cambridge, Massachusetts, 2018
- Speaker, "Maximizing Ownership of Your Healthcare Start-Up," MIT Martin Trust Center, Cambridge, Massachusetts, 2017
- Speaker, "Fundamentals of Fundraising," inSite at Harvard Business School/MIT Sloan, Cambridge, Massachusetts, 2017
Select Publications
- Author, “Evaluating Prospective Partners When Scaling Your Digital Health Company,” Digital Health Report,. Spring/Summer Q2 2018
- Co-author, "The Serious and Immense Impact of a Medical Device Hack," Law360, January 12, 2017
- Co-author with K. Ludlow, D.M. Bowman, and M.G. Bennett, "Regulating Emerging and Future Technologies in the Present," 9 NanoEthics 151, 2015
- Co-author with D.M. Bowman, "Reviewing the Regulatory Barriers for Nanomedicine: Global Questions and Challenges," 10(21) Nanomedicine 3275-86, 2015
Select Speaking Engagements
- Speaker, “Term Sheet Tear-Down," inSite at Harvard Business School/MIT Sloan, Cambridge, Massachusetts, 2018
- Speaker, "Maximizing Ownership of Your Healthcare Start-Up," MIT Martin Trust Center, Cambridge, Massachusetts, 2017
- Speaker, "Fundamentals of Fundraising," inSite at Harvard Business School/MIT Sloan, Cambridge, Massachusetts, 2017
- Privacy Policy
- Terms of Use
- Accessibility